
Nuclear medicine imaging services in Medicare 011-20021124

-   Background
-   References
-   Resources
-   Training & Support

[Expand/Collapse all sections]Expand all

MBS item numbers – Positron Emission Tomography (PET)

Table 1: click on the links in the table to see the items per region for
PET studies

+-----------------------------------+-----------------------------------+
| Region                            | Items                             |
+-----------------------------------+-----------------------------------+
| Whole body                        | Whole body PET items              |
+-----------------------------------+-----------------------------------+
| Brain                             | Brain PET items                   |
+-----------------------------------+-----------------------------------+

MBS item numbers – Myocardial Perfusion Studies

Table 2: click on the link in this table to see the item numbers

+-----------------------------------+-----------------------------------+
| Details                           | Items                             |
+-----------------------------------+-----------------------------------+
| Items for health professionals    | Remote area myocardial perfusion  |
| performing services in remote     | study items                       |
| areas (Modified Monash Model      |                                   |
| areas 3-7) where stress           |                                   |
| echocardiogram services are not   |                                   |
| available.                        |                                   |
+-----------------------------------+-----------------------------------+

Temporary nuclear medicine items- Availability dates

Table 3: temporary nuclear medicine items may only be claimed for
services provided during the available dates if the patient has a valid
request.

+-----------------------+-----------------------+-----------------------+
| Item                  | Details               | Availability period   |
+-----------------------+-----------------------+-----------------------+
| 61311                 | Single stress         | 1 December 2020 – 28  |
|                       | myocardial perfusion  | February 2021         |
|                       | study - with PET      |                       |
|                       |                       | 14 September 2019 –   |
|                       |                       | 20 December 2019      |
+-----------------------+-----------------------+-----------------------+
| 61332                 | Combined stress and   | 1 December 2020 – 28  |
|                       | rest, stress and      | February 2021         |
|                       | re‑injection or rest  |                       |
|                       | and redistribution    | 14 September 2019 –   |
|                       | myocardial perfusion  | 20 December 2019      |
|                       | study - with PET.     |                       |
+-----------------------+-----------------------+-----------------------+
| 61333                 | Lung perfusion study  | 1 December 2020 – 28  |
|                       | and lung ventilation  | February 2021         |
|                       | study using galligas  |                       |
|                       | or 68Ga-MAA - with    | 14 September 2019 –   |
|                       | PET.                  | 20 December 2019      |
+-----------------------+-----------------------+-----------------------+
| 61336                 | Cerebral perfusion    | 1 December 2020 – 28  |
|                       | study, with PET.      | February 2021         |
|                       |                       |                       |
|                       |                       | 14 September 2019 –   |
|                       |                       | 20 December 2019      |
+-----------------------+-----------------------+-----------------------+
| 61337                 | Bone study - whole    | December 2020 – 28    |
|                       | body, with PET.       | February 2021         |
|                       |                       |                       |
|                       |                       | 14 September 2019 –   |
|                       |                       | 20 December 2019      |
+-----------------------+-----------------------+-----------------------+
| 61341                 | Bone study - whole    | 1 December 2020 – 28  |
|                       | body and PET.         | February 2021         |
|                       |                       |                       |
|                       |                       | 14 September 2019 –   |
|                       |                       | 20 December 2019      |
+-----------------------+-----------------------+-----------------------+
| 61344                 | CT claimable with the | 1 December 2020 – 28  |
|                       | temporary items       | February 2021         |
|                       | 61311, 61332, 61333,  |                       |
|                       | 61336, 61337 and      | 14 September 2019 –   |
|                       | 61341.                | 20 December 2019      |
+-----------------------+-----------------------+-----------------------+
| 61365                 | Repeat combined       | 1 December 2020 – 28  |
|                       | stress and rest,      | February 2021         |
|                       | stress and            |                       |
|                       | re-injection or rest  |                       |
|                       | and redistribution    |                       |
|                       | myocardial perfusion  |                       |
|                       | study.                |                       |
+-----------------------+-----------------------+-----------------------+
| 61377                 | Single stress         | 1 December 2020 – 28  |
|                       | myocardial perfusion  | February 2021         |
|                       | study, with PET.      |                       |
+-----------------------+-----------------------+-----------------------+
| 61380                 | Combined stress and   | 1 December 2020 – 28  |
|                       | rest, stress and      | February 2021         |
|                       | re-injection or rest  |                       |
|                       | and redistribution    |                       |
|                       | myocardial perfusion  |                       |
|                       | study.                |                       |
+-----------------------+-----------------------+-----------------------+
| 61418                 | Repeat combined       | 1 December 2020 – 28  |
|                       | stress and rest,      | February 2021         |
|                       | stress and            |                       |
|                       | re-injection or rest  |                       |
|                       | and redistribution    |                       |
|                       | myocardial perfusion  |                       |
|                       | study.                |                       |
+-----------------------+-----------------------+-----------------------+
| 61422                 | Single rest           | 1 December 2020 – 28  |
|                       | myocardial perfusion  | February 2021         |
|                       | study for the         |                       |
|                       | assessment of the     |                       |
|                       | extent and severity   |                       |
|                       | of viable and         |                       |
|                       | non-viable            |                       |
|                       | myocardium, with PET. |                       |
+-----------------------+-----------------------+-----------------------+
| 61527                 | Whole body study      | 1 August 2022 –       |
|                       | using PET, if the     | onwards               |
|                       | service is performed  |                       |
|                       | because the services  | The supply            |
|                       | to which items 61429, | disruptions are       |
|                       | 61430, 61442, 61450   | expected to continue  |
|                       | or 61453 apply cannot | for a significant     |
|                       | be performed due to   | time. The end date    |
|                       | unavailability of     | will be applied to    |
|                       | gallium-67            | the item when advised |
|                       |                       | by the Department of  |
|                       |                       | Health and Aged Care. |
+-----------------------+-----------------------+-----------------------+
| 61644                 | Single rest           | 1 April 2022 - 30     |
|                       | myocardial perfusion  | September 2022        |
|                       | study for the         |                       |
|                       | assessment of the     |                       |
|                       | extent and severity   |                       |
|                       | of non-viable         |                       |
|                       | myocardium, with PET. |                       |
+-----------------------+-----------------------+-----------------------+

Services Australia website

Medicare eligibility to provide diagnostic imaging and radiation
oncology services

External links

Department of Health and Aged Care

MBS Online

MBS explanatory note IN.0.17 Group I4 – Nuclear Medicine Imaging

MBS Online – Category 5, Group I4

MBS Online – Category 5, Group I4, Subgroup 1 – non PET

PET Items

Whole body PET Items

Brain PET Items

Remote area myocardial perfusion study items

                                   

-   Services Australia ABN 90 794 605 008 
